PAIN TRIGGERS
Widespread inability to find Adderall or alternatives in stock at pharmacies
Shortages severely disrupt daily life, work, and mental health after years of stable treatment
SaaS· ADHD patients on long-term stimulant medicationPain 8.00/10WTP 8.0/10Market 9.0/10Validation 9.0Confidence 72%May 28, 2026
StockPulse ADHD: Real-Time Pharmacy Locator for Stimulant Meds
Nationwide shortages of Adderall and stimulant alternatives leave compliant patients unable to fill prescriptions, causing severe daily functioning breakdowns.
adhdchronic-conditionhealthcaremedication-managementmobile-appproductivitysaastelehealthwellness
1
STAGE 01 · PROBLEM
Is the problem real?
CANONICAL PROBLEM
ADHD patients cannot reliably access prescribed Adderall or alternative stimulants due to ongoing nationwide shortages and supply chain issues.
FREQUENCY
Multiple repeated complaints in the post and comments.
INTENSITY
Users explicitly describe existing tools as bloated/overkill and mention workaround behavior.
EVIDENCE
"I paid $7 per 20mg pill to someone who had extra"
commentI paid $7 per 20mg pill to someone who had extra, which is an insane 'street' price. I needed about a weeks worth to hold me over and i was taking half of what i should be just to get out of bed in the morning without feeling like crap. It's absolutely wild out there. When I was in NYC (i moved recently) I would walk to the pharmacy or call three others every other day for sometimes two whole weeks trying to get my hands on something just to function. I'm self employed and I can't afford to be exhausted and unproductive the way I could slump through work in a corporate environment and pretend. So I can completely relate, and it's so unfair. I hope things get better soon for you. I also had to wait THREE MONTHS to get an appointment with a GP in a new town, they refused to prescribe me anything unless I was sick and needed an emergency appt. I don't know what the answer is to filter out the people who don't need it, but I'm just tired ): i'm hoping things will be easier now that I live in a town with less people and more transient tourists but we will see.
"Every CVS around the triangle area in NC seems to be out"
commentYep. Every CVS around the triangle area in NC seems to be out. Going back to Vyvanse for now.
2
STAGE 02 · CUSTOMER
Who feels this pain?
TARGET USERS
ADHD patients on long-term stimulant medicationA D H D Adults On Adderall Or Alternatives
Working adults managing ADHD with daily stimulant prescriptions who experience sudden unavailability disrupting work, life stability, and mental health.
Context
Consistently obtain and refill ADHD medication to maintain daily functioning, productivity, and mental health stability.
Calling multiple pharmacies repeatedly and driving to check in person
Switching to alternative medications or formulations like methylphenidate, Concerta, dextroamphetamine, or Vyvanse
Current Workarounds
Calling dozens of pharmacies daily and driving long distances
Switching between Adderall, Vyvanse, Concerta or other formulations
Relying on caffeine or grey market sources during shortages
Using hospital or independent pharmacies as backup
3
STAGE 03 · MARKET
Where's the gap?
EXISTING SOLUTION GAPS
Standard pharmacy calling and stock checks fail due to pharmacists being trained to deny availability for controlled substances
Major chain pharmacies (CVS, Walgreens) consistently out of stock with unpredictable backorders
DEA manufacturing quotas and external factors make supply unreliable despite following all rules and long-term compliance
OPPORTUNITY & VALUE
Why Now
Multiple reports across states confirming nationwide shortages severely impacting daily life and driving risky behaviors.
Value Proposition
Hyper-focused on ADHD controlled stimulants with crowdsourced verification and direct telehealth handoff for shortages, unlike general price tools.
Product Direction
Crowdsourced real-time availability tracker and alert app for ADHD stimulants that reports pharmacy stock, suggests nearby alternatives, and connects to telehealth for legal switches.
4
STAGE 04 · BUSINESS
How does it make money?
MONETIZATION
$19/moPremium alerts and priority telehealth
Model
SaaS subscription
WILLINGNESS TO PAY
Users describe medication unavailability as "life-ruining" after years of stability and are already paying $7/pill on grey market; $19/mo is minor compared to lost productivity and mental health costs.
5
STAGE 05 · EXECUTION
How do you ship it?
MVP PLAN
“Never miss your ADHD medication refill again due to shortages.”
Crowdsourced real-time availability tracker and alert app for ADHD stimulants that reports pharmacy stock, suggests nearby alternatives, and connects to telehealth for legal switches.
Core Features
User-reported pharmacy stock updates for Adderall/Vyvanse
Location-based search and push alerts for availability
Alternative medication suggestions and telehealth referral
Personal refill history and shortage impact tracker
Weekly Roadmap
1
W1-W2
Core location and reporting backend operational.
- •Build user authentication and profile with location
- •Create pharmacy stock submission form
- •Implement basic map search UI
2
W3-W4
Real-time alerts and alternative suggestions complete.
- •Develop push notification system for stock matches
- •Add medication alternative database
- •Integrate simple telehealth referral links
3
W5
Internal testing with 20 beta ADHD users.
- •Recruit beta testers from Reddit ADHD forums
- •Polish UI/UX for mobile-first experience
- •Implement basic moderation for reports
4
W6
Public beta launch with first subscribers.
- •Stripe subscription setup
- •Launch announcement in ADHD communities
- •Track usage metrics and first conversions
Launch Strategy
Launch in r/ADHD, r/ADHDers, and X communities with targeted ads to adults discussing shortages in NC, WA, NY regions.
RISKS & ASSUMPTIONS
Top Risks
DEA Regulatory Restrictions
Handling data on controlled substances may trigger legal scrutiny or limit features around reporting.
Crowdsourced Data Reliability
Users may post inaccurate or outdated stock information leading to frustration and churn.
Low Pharmacist Cooperation
Pharmacies are trained not to disclose controlled substance availability over phone.
Grey Market Competition
Desperate users may continue risky workarounds instead of adopting the app.
6
STAGE 06 · DECISION
Should you build it?
NEED A CLEARER CALL?
Run an Investment Memo to get a structured Go / No-Go verdict, competitor landscape, unit economics, and a 90-day validation roadmap for this opportunity.
Generate an investment memoWhat this score means
This opportunity scores well above the median for ideas surfaced by MonetScope, with a validation sub-score of 9/10 against 4 independently sourced evidence signals. A "strong" rating in this band typically means the pain signal is consistent and recurring across multiple discussions, but one of the three pillars (severity, willingness to pay, or competitor weakness) is somewhat softer than top-tier opportunities. Founders evaluating this should focus customer discovery on the softest pillar first — confirming the gap before committing engineering time to a build.
Why this matters for SaaS founders
It sits at the intersection of "adhd", "chronic-condition", "healthcare", which makes it relevant to a specific subset of founders rather than a generic horizontal opportunity. SaaS opportunities at this stage tend to win on the strength of their initial wedge — a single workflow that the target user runs every week, where the existing solution is either spreadsheets, a clunky incumbent feature, or a manual process they hate. The build cost is moderate; the distribution cost is everything. The MonetScope pipeline surfaces this category alongside other saas signals, which is why it appears here rather than in a generic "trending ideas" feed.
Scores are derived from real forum discussions across Reddit, Hacker News and X, weighted by evidence volume and signal quality. How scoring works
Frequently asked questions
Is "StockPulse ADHD: Real-Time Pharmacy Locator for Stimulant Meds" a real validated startup idea or just an AI-generated suggestion?
MonetScope does not generate ideas from a language model's imagination. Every opportunity on this site is anchored to specific source posts and comments from real public discussions — typically on Reddit, Hacker News, or X — where actual users describe the pain in their own words. The AI's role is structuring, scoring, and grouping those signals into a navigable opportunity, not inventing the problem.
How recent is the underlying data for adhd?
MonetScope's spider pipeline runs continuously and surfaces opportunities as new evidence accumulates. The "Updated" date in the header reflects the most recent re-scoring of this specific opportunity. Most saas opportunities visible in the public catalog draw from discussions in the last 30-60 days; older signals are de-prioritized because user pain shifts faster than most founders assume.
What's the difference between "overall score" and "validation score"?
Overall score is a composite across six dimensions — pain, urgency, willingness to pay, market size, defensibility, and execution ease — designed to give a single number for triage. Validation score is narrower: it asks "how cleanly does the same signal repeat across independent sources?" An opportunity can score high on overall but lower on validation when one or two large discussions dominate the evidence; conversely, validation can be high on a smaller-overall idea where the signal is consistent but the addressable market is modest.